USFDA

ISPE

MHRA

WHO

PIC/S

QC

USFDA

ISPE

MHRA

WHO

PIC/S

QC

USFDA

ISPE

MHRA

WHO

PIC/S

QC

USFDA

ISPE

MHRA

WHO

PIC/S

QC

USFDA

ISPE

MHRA

WHO

PIC/S

QC

USFDA

ISPE

MHRA

WHO

PIC/S

QC

Our Forte

Pharma Access has distinct capabilities of handling high potent compounds especially in the area of oncology, hormones that helps us to become a preferred partner of choice!

Specialized Formulation

Our sustenance to specialized formulations manufacturers encompasses the complete lifecycle of the hi- potent product, from the initial idea to enhancing the operation of established commercial manufacturing facilities. Our experience in executing projects for this segment covers cytotoxic drugs, hormonal formulations and special formulation like transdermal patches This includes applying our manufacturing experience into facility design, while ensuring the following aspects:

  • Preventing cross contamination
  • Process architecture
  • Segregation concept
  • Process flexibility
  • Regulatory considerations
Oncology
Hormones
Transdermal
Inhalations (MDI & DPI)

From last 18 years Pharma Access has helped clients manage their challenges related to oncology, hormonal drugs production by:

  • Formulating strategies for future changes in the product portfolio
  • Applying industry standards for qualification and validation activities
  • Supporting cost-effective solutions
  • Providing top quality equipment for manufacturing the forms

Major Projects

Specialized Formulation Project In Saudi Arabia

The company was established in 1973 is one of the industry leaders offers solution for various sectors like Oil and gas. Renovation and Construction, Electrical Services, Mechanical and Plumbing Services, Solid Waste management, Contract Cleaning Services and Skilled Manpower Supply in the Kingdom of Saudi Arabia.

The greenfield project represents the group’s first venture into the field pf Pharmaceuticals to manufacture Oncological Tablets, Capsules and Injectables on its land located in Dammam, Saudi Arabia.

Quick Facts

  • Client Name: Confidential
  • Country: Saudi Arabia
  • Total size of investment: $ 20 Million
  • Scope of Pharma Access: Complete Engineering consultancy with conceptual, basic and detailed designs.

Boston Oncology- Syria

The project comprised of formulation of oncology drugs for the following forms and capacities:
Oral Solid Dosage- Tablets- Pilot line of 5 kg
Sterile Form- Liquid and lyophilized ampoules and vials

Pharma Access successfully completed this project by providing the complete engineering consultancy and executing the project by supply, installation and commissioning of process equipment for the tablet and the filling line

Main Pharma- Syria

Pharma Access successfully supplied, installed and commissioned isolators, tablet compression machine, packaging machines and clean room equipment for the manufacturing of oncology cytotoxic tablets and capsules.

Related Projects